Laboratoire d'Innovation Thérapeutique - LIT - UMR7200

  • Flux RSS
(1 - 20 of 44)

Pages

Aerobic Copper-Mediated Domino Three-Component Approach to 2-Aminobenzothiazole Derivatives
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice
Bioactive Flavaglines: Synthesis and Pharmacology
Composition contenant au moins un inhibiteur de certaines chimiokines, son procédé d’obtention et son utilisation en dermocosmétique pharmaceutique
Contrôle qualité des chimiothèques. [= Quality control of chemical libraries]
CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcript
Deciphering of the mechanism of the anti-asthmatic action of the CXCL12 neutraligand, chalcone 4
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors
Development of Dipeptidic hGPR54 Agonists.
Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors
Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1
Flavaglines as Potent Anticancer and Cytoprotective Agents
Fluorescent dyes and dye precursors
Fluorogenic squaraine dimers with polarity-sensitive folding as bright far-red probes for background-free bioimaging
Inhibitors of the interaction between a protein belonging to GPRASP protein family and a protein belonging to GPCR protein family and their use as drugs
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments
Isolation of novel stilbenoids from the roots of Cyrtopodium paniculatum (Orchidaceae)
Les neutraligands à l'assaut des chimiokines

Pages